The aiSLE DX Flare Risk Index test
The test is called the aiSLE DX Flare Risk Index, produced by Progentec Diagnostics, a company that specializing in lupus. This is the first test in their “pipeline” (the yellow “01” part of the diagram above) of lab tests, designed to modernize and improve the care of SLE patients. Progentec had a press release this week about the lab test… read it here
The test measures numerous molecules of the immune system called cytokines and chemokines. Some of these cytokines increase immune system activity in SLE, while others decrease it. Studies have shown (at the Mayo Clinic and OMRF) that before lupus flares, we can predict the chances of it occurring beforehand. This is exciting. Up to now, whenever we get labs on our lupus patients, it tells us how patients are doing at this moment. I like the way that Dr. Chaim Putterman (a lupologist) put it:
“The management of lupus symptoms has traditionally involved a regimen of reactive protocols. A test that assesses the likely risk of the onset of a flare is one of the first proactive measures available to the rheumatological community. The empirical data derived from such a test potentially has tremendous value in helping devise the right treatment and care for lupus patients.”
– Chaim Putterman, MD is a Professor of Medicine and Microbiology & Immunology at the Albert Einstein College of Medicine
Under a dozen rheumatologists have been using it up to now, but this week it has gone commercial. Rheumatologists can go to the Progentec website to sign up for the test so they can offer them to their patients.
Share any comments below. If you have lupus, what do you think of new tests coming out such as this?
SHARE the good news that the medical care of lupus patients is advancing!
Don Thomas, MD
Rheumatologist caring for lupus patients